Edgewise Therapeutics EWTX
NASDAQ EWTX
$43.07 +1.12 (+2.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026)

Edgewise Therapeutics (EWTX) posted Amortizatization of Intangibles of $1.0 million for Q1 2026, down 31.69% sequentially from $1.5 million in Q4 2025, and up 2370.73% YoY from $41000.0 in Q1 2025.

Analysis

Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Edgewise Therapeutics has reported Amortizatization of Intangibles for 5 years, with the latest figure at $1.0 million in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 2370.73% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 399.07% YoY) and the FY2025 annual result came in at $7.7 million, up 3368.33% from the prior year.
  • Amortizatization of Intangibles fell to $1.0 million in Q1 2026 per EWTX's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $9.4 million in Q4 2023 and troughed at -$6.5 million in Q3 2024.
  • A 5-year average of $1.1 million and a median of $771000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles plunged 13712.5% in 2024, then surged 2751.92% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $377000.0 in 2022, then surged by 2389.66% to $9.4 million in 2023, then plunged by 99.45% to $52000.0 in 2024, then soared by 2751.92% to $1.5 million in 2025, then tumbled by 31.69% to $1.0 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.0 million, $1.5 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Edgewise Therapeutics 4.65 Bn 4.65 Bn - 809,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 809,000.00
Mar 31, 2026 1.01 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 2.06 Mn
Jun 30, 2025 2.20 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.55 Mn
Mar 31, 2024 3.15 Mn
Dec 31, 2023 2.17 Mn
Sep 30, 2023 2.38 Mn
Jun 30, 2023 2.90 Mn
Mar 31, 2023 2.08 Mn
Dec 31, 2022 1.76 Mn
Sep 30, 2022 -127,000.00
Jun 30, 2022 -415,000.00
Mar 31, 2022 -670,000.00